What are the treatment options for a patient with trichotillomania, trichomoniasis, or trichinosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

The first-line treatment for trichomoniasis is metronidazole 2g orally as a single dose, which achieves cure rates of 90-95%. 1, 2

Primary Treatment Regimens

  • Metronidazole 2g orally as a single dose is the CDC-recommended first-line treatment 3, 1, 2
  • Alternative regimen: Metronidazole 500mg orally twice daily for 7 days may be more effective (89% vs 81% cure rate) and is preferred if compliance with multi-dose therapy is reliable 3, 1
  • Tinidazole 2g orally as a single dose is an FDA-approved alternative with cure rates ranging from 92-100% in clinical trials 4

Critical Management Requirements

Partner Treatment (Mandatory)

  • All sexual partners must be treated simultaneously, regardless of symptoms or test results, as this is the most common cause of treatment failure 1, 5, 2
  • Most infected men are asymptomatic carriers, making them unknowing vectors of transmission 5
  • Patients must abstain from all sexual activity until both partners complete treatment and are asymptomatic 3, 1, 5

Common Pitfall to Avoid

  • Never use metronidazole vaginal gel for trichomoniasis—it achieves <50% efficacy and is only approved for bacterial vaginosis 1, 5, 2
  • Topical preparations are ineffective and should never be used 1

Treatment Failure Protocol

When reinfection from untreated partners has been excluded:

  • First failure: Re-treat with metronidazole 500mg twice daily for 7 days 3, 1, 2
  • Second failure: Metronidazole 2g once daily for 3-5 days 3, 1, 2
  • Persistent failure: Consult infectious disease specialist for susceptibility testing 1, 2

Special Populations

Pregnancy

  • First trimester: Treatment must be delayed until second trimester begins, as metronidazole is contraindicated during organogenesis 5
  • Second and third trimesters: Metronidazole 2g single dose is recommended (preferred over 7-day regimen to minimize fetal drug exposure) 3, 5
  • Treatment after first trimester is warranted because trichomoniasis is associated with premature rupture of membranes, preterm delivery, and low birth weight 5, 2

Breastfeeding

  • The 7-day regimen (metronidazole 500mg twice daily) may be preferred if the patient cannot interrupt breastfeeding, as the lower daily dose results in less drug accumulation in breast milk 1

HIV-Infected Patients

  • Use the same treatment regimens as HIV-negative patients 3, 1, 2
  • Treatment is particularly important as untreated trichomoniasis increases HIV transmission risk 2

Metronidazole Allergy

  • Desensitization is the recommended approach, as effective alternatives to nitroimidazoles do not exist 3, 2
  • Desensitization protocols are specifically recommended by CDC guidelines 2

Patient Counseling Points

  • Avoid all alcohol during treatment and for 24-48 hours after the last dose to prevent severe disulfiram-like reactions 1, 5
  • Follow-up is unnecessary for patients who become asymptomatic after treatment 3, 2
  • Reinfection from untreated partners is the most common cause of apparent treatment failure 2

References

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment and Prevention of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.